Whitepapers

Nov 02, 2016
Sponsored Content
Read this guide to learn how to improve quality oversight for your global pharmaceutical company, including: • Five steps to aligning quality at your organization • Practical recommendations to improve collaboration • Ways to balance global and local needs • Common mistakes in quality harmonization initiatives
Oct 27, 2016
Sponsored Content
By AHM
Despite the Open Payments Program, HCPs continue to support interactions with Life Sciences companies. Learn what HCPs value when participating in promotional programs and why they continue to support these interactions.
Oct 25, 2016
Sponsored Content
Orchestrated Customer Engagement (OCE) is a new concept based on the principle of establishing greater trust between Life Sciences companies and their customers.
Oct 13, 2016
Sponsored Content
By Meta
Scanning the scientific, technical and medical horizon for signs of future emergence.
Oct 06, 2016
Sponsored Content
Pharm Exec convened a roundtable discussion during the 2016 American Society of Clinical Oncology Annual meeting to examine a central question in cancer treatment today: what is the appropriate role of patient-reported outcome (PRO) measures in driving a drug evaluation model that incorporates insights from the real-life patient experience?
Sep 30, 2016
Sponsored Content
Inaugural Benchmarking Data on HCP Meetings and Engagements: The Industry’s biggest challenge when managing HCP meetings and engagements. Review of the gaps and suboptimal processes and systems currently used today to compliantly manage HCP meetings and engagements.
Sep 29, 2016
Pharmaceutical Executive
Biopharma companies face significant complexity. This insight brief will help you learn how to align all aspects of marketed product maintenance (including regulatory, safety and benefit-risk management) to improve compliance and reduce complexity and cost.
Sep 29, 2016
Pharmaceutical Executive
View this infographic to see how Quintiles helps anticipate and address the complex challenges of rare disease studies by bringing together a specialized team with rare disease experience and therapeutic expertise, along with tailored patient-centric approaches to global study planning and execution in order to speed treatments to market to transform the lives of patients and their families
Sep 29, 2016
Pharmaceutical Executive
Quintiles is an experienced partner who can help biopharmaceutical companies simplify the complexities of rare disease studies to speed new treatments to market for patients and their families. Read this compendia featuring blogs and bylined articles from Quintiles’ experts to learn more.
Sep 27, 2016
Pharmaceutical Executive
Join Randolph Carpio from Quintiles, and Joe Bonaccorso from Pierre Fabre as they discuss the importance of getting the reimbursement, access and distribution strategy correct to make the most of the opportunities in the U.S.
native1_300x100
lorem ipsum